Trial Profile
Effect of bosentan and iloprost on peripheral blood perfusion in patients with systemic sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Bosentan (Primary) ; Iloprost
- Indications Systemic scleroderma
- Focus Therapeutic Use
- 08 Dec 2015 New trial record